Forecast for rapid growth by 2033, with disease-
Author: Michael
Arvinas presented early biomarker data on ARV-10
Better U and Evernow have joined forces to pair
QIMA Life Sciences launches SQINGEVITY, bringing
Small open-label study of ATR-258 saw fat loss,
IBio’s eight-week obese nonhuman primate study
The United States Patent and Trademark Office has
United Therapeutics will present two oral and fiv
Boehringer Ingelheim widens its kidney-disease p
A two-year partnership with Ultrahuman aims to c